CHEMICAL RESEARCH IN TOXICOLOGY OPTIONS

Tirzepatide being a twin GLP-1 and GIP agonist, it is actually suggested that the GIP part of dual agonism may very well be liable for the additional advantage, given the probable advantage of GIP receptor agonism on peripheral insulin sensitization. For that reason, tirzepatide was more effective than dulaglutide in reducing fasting dietary TAG [